Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-012200
Filing Date
2025-02-12
Accepted
2025-02-12 16:22:10
Documents
1
Period of Report
2025-02-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm256369-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm256369-4_4seq1.xml 4 4140
  Complete submission text file 0001104659-25-012200.txt   5598
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOYAGER THERAPEUTICS, INC. 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Carter Todd Alfred (Reporting) CIK: 0001944011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 25615158